Zoom link => https://us02web.zoom.us/j/89828059580
Using genomics to advance the field of Maladie de Charcot
Bryan Traynor
Chief, Neuromuscular Diseases Research Section, Laboratory of Neurogenetics, National
Institute on Aging (NIA), National Institutes of Health (NIH), Bethesda, MD, USA
Bryan J. Traynor is a neurologist and Senior Investigator at the National Institute on Aging, and adjunct faculty at Johns Hopkins University and Queen Square Institute of Neurology, UCL. He is best known for his work to understand the genetic etiology of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). He led the international consortium that identified pathogenic repeat expansions in C9orf72 as a common cause of ALS and FTD. Other genes discovered by his laboratory as causes of ALS and FTD include VCP, MATR3, KIF5A and HTT. His principal interests are in ALS, FTD, myasthenia gravis, and genomics.
Summary: I will discuss how genomics has advanced our understanding of amyotrophic lateral sclerosis (ALS) by finding new genes and providing us with the tools to unlock the mysteries of this disease first described Charcot all those years ago.
